ARCHIVES

J&J, Amgen Settle Lawsuit Over ESAs As FDA Prepares Another Label Change.

This article is from The Cancer Letter archive.

Vol. 34 No. 28 | July 18, 2008

Download PDF Visit The Full Archive

Related Articles

Hearing Scheduled To Investigate ImClone’s C225 Development, Stock Trading

June 7, 2002

In brief: Cancer Investment “Drop In The Bucket,” OMB Is The “Second Greatest Kill,” Pepper Says

August 10, 1979

Clinical Education Grants Held To 170 Payline, No New Awards; Organ Site Renewals Limited To 180

March 26, 1982

NCI-Approved Clinical Trials

January 26, 2007

NCI-Approved Clinical Trials

December 31, 2004

NIH Probing: Double Dipping” Allegation

September 4, 1981